Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 628

  • Unknown field was ignored: [Corporate%252520Author].
1.

Dynamin-like protein 1 cleavage by calpain in Alzheimer's disease.

Jiang S, Shao C, Tang F, Wang W, Zhu X.

Aging Cell. 2019 Feb 14:e12912. doi: 10.1111/acel.12912. [Epub ahead of print]

PMID:
30767411
2.

Tau drives translational selectivity by interacting with ribosomal proteins.

Koren SA, Hamm MJ, Meier SE, Weiss BE, Nation GK, Chishti EA, Arango JP, Chen J, Zhu H, Blalock EM, Abisambra JF.

Acta Neuropathol. 2019 Feb 13. doi: 10.1007/s00401-019-01970-9. [Epub ahead of print]

PMID:
30759285
3.

Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.

Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzmán-Vélez E, Jacobs HIL, Hanseeuw B, Pardilla-Delgado E, Artola A, Baena A, Bocanegra Y, Kosik KS, Chen K, Tariot PN, Johnson K, Sperling RA, Reiman EM, Lopera F, Quiroz YT.

J Prev Alzheimers Dis. 2019;6(2):112-120. doi: 10.14283/jpad.2019.6.

PMID:
30756118
4.

Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer's Progression in Real Life (iMAP) Study.

Graf A, Risson V, Gustavsson A, Bezlyak V, Caputo A, Tariot PN, Langbaum JB, Lopez Lopez C, Viglietta V.

J Prev Alzheimers Dis. 2019;6(2):85-89. doi: 10.14283/jpad.2018.49.

PMID:
30756114
5.

Association between TDP-43 and mitochondria in inclusion body myositis.

Huntley ML, Gao J, Termsarasab P, Wang L, Zeng S, Thammongkolchai T, Liu Y, Cohen ML, Wang X.

Lab Invest. 2019 Feb 11. doi: 10.1038/s41374-019-0233-x. [Epub ahead of print]

PMID:
30742062
6.

Using social media to disseminate education about Alzheimer's prevention & treatment: a pilot study on Alzheimer's universe (www.AlzU.org).

Isaacson RS, Seifan A, Haddox CL, Mureb M, Rahman A, Scheyer O, Hackett K, Caesar E, Chen JL, Isaacson J, McInnis M, Mosconi L, Safdieh J.

J Commun Healthc. 2018;11(2):106-113. doi: 10.1080/17538068.2018.1467068. Epub 2018 May 5.

7.

Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.

Li L, Jiang Y, Hu W, Tung YC, Dai C, Chu D, Gong CX, Iqbal K, Liu F.

Mol Neurobiol. 2019 Feb 8. doi: 10.1007/s12035-019-1507-4. [Epub ahead of print]

PMID:
30734228
8.

Hydroxytryptamine transporter gene-linked polymorphic region (5HTTLPR) is associated with delusions in Alzheimer's disease.

D'Onofrio G, Panza F, Sancarlo D, Lauriola M, Dagostino MP, Paroni G, Lozupone M, Mangiacotti A, Bisceglia P, Gravina C, Urbano M, Addante F, Paris F, Cascavilla L, Greco A, Seripa D.

Transl Neurodegener. 2019 Feb 1;8:4. doi: 10.1186/s40035-019-0144-1. eCollection 2019.

9.

iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context.

Ihnatovych I, Nayak TK, Ouf A, Sule N, Birkaya B, Chaves L, Auerbach A, Szigeti K.

Transl Psychiatry. 2019 Feb 1;9(1):59. doi: 10.1038/s41398-019-0375-z.

10.

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.

Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, Seeley WW, Ramos EM, Coppola G, Gorno-Tempini ML, Miller BL, Rosen HJ, Jagust W, Boxer AL, Rabinovici GD.

Alzheimers Res Ther. 2019 Jan 31;11(1):13. doi: 10.1186/s13195-019-0470-7.

11.

Preapproval Information Exchange: Perspectives of U.S. Population Health Decision Makers on Preferences for Early Engagement with Investigational Therapies.

Brixner D, Woodward TC, Seifter N, Biskupiak J, Marciniak M, Neumann P, Oderda G.

J Manag Care Spec Pharm. 2019 Feb;25(2):164-173. doi: 10.18553/jmcp.2019.25.2.164.

12.

Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, Guillo Benarous F, Ulysse A, Oo T, Vedvyas A, Rao JA, Marsh K, Kluger A, Sangha J, Hassan M, Alshalabi M, Arain F, Shaikh N, Buj M, Kenowsky S, Masurkar AV, Rabin L, Noroozian M, Sánchez-Saudinós MAB, Blesa R, Auer S, Zhang Y, de Leon M, Sadowski M, Wisniewski T, Gauthier S, Shao Y.

J Alzheimers Dis. 2019;67(2):685-705. doi: 10.3233/JAD-180341.

PMID:
30689585
13.

The Effect of a Comprehensive Dementia Care Management Program on End-of-Life Care.

Jennings LA, Turner M, Keebler C, Burton CH, Romero T, Wenger NS, Reuben DB.

J Am Geriatr Soc. 2019 Jan 24. doi: 10.1111/jgs.15769. [Epub ahead of print]

PMID:
30675898
14.

Associations between handgrip strength and mild cognitive impairment in middle-aged and older adults in six low- and middle income countries.

Vancampfort D, Stubbs B, Firth J, Smith L, Swinnen N, Koyanagi A.

Int J Geriatr Psychiatry. 2019 Jan 22. doi: 10.1002/gps.5061. [Epub ahead of print]

PMID:
30672025
15.

Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.

Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P.

Alzheimers Res Ther. 2019 Jan 15;11(1):7. doi: 10.1186/s13195-018-0459-7.

16.

The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.

McCleery J, Flicker L, Richard E, Quinn TJ.

Alzheimers Dement. 2019 Jan;15(1):179-181. doi: 10.1016/j.jalz.2018.10.007. No abstract available.

PMID:
30642437
17.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O'Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV.

Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.

PMID:
30642436
18.

Causes and Patterns of Dementia: An Update in the Era of Redefining Alzheimer's Disease.

James BD, Bennett DA.

Annu Rev Public Health. 2019 Jan 14. doi: 10.1146/annurev-publhealth-040218-043758. [Epub ahead of print]

PMID:
30642228
19.

Semiautomated Assessment of the Anterior Cingulate Cortex in Alzheimer's Disease.

Jung F, Kazemifar S, Bartha R, Rajakumar N.

J Neuroimaging. 2019 Jan 14. doi: 10.1111/jon.12598. [Epub ahead of print]

PMID:
30640412
20.

Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments.

Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Czaja SJ, Loewenstein DA, Johnson KA, Sperling RA, Rentz DM.

Alzheimers Res Ther. 2019 Jan 10;11(1):4. doi: 10.1186/s13195-018-0464-x.

Supplemental Content

Loading ...
Support Center